| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/19/2007 | WO2006047451A3 Immunoassays for lamotrigine |
| 04/19/2007 | WO2006041970A8 Treatment of respiratory syncytial virus (rsv) infection |
| 04/19/2007 | WO2006040153A3 Single domain camelide anti -amyloid beta antibodies and polypeptides comprising the same for the treatment and diagnosis of degenarative neural diseases such as alzheimer's disease |
| 04/19/2007 | WO2005056802A3 Materials and methods relating to cell cycle control |
| 04/19/2007 | WO2005007671A3 Compositions and methods for treating sars |
| 04/19/2007 | US20070089201 Plant production of immunoglobulins with reduced fucosylation |
| 04/19/2007 | US20070089182 Regeneration |
| 04/19/2007 | US20070089176 Cytokine involved in epithelial-mesenchymal transition |
| 04/19/2007 | US20070088151 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/19/2007 | US20070088104 Temperature regulating gel and article comprising the same |
| 04/19/2007 | US20070087970 Use of C-reactive protein to treat immune complex-mediated renal disease |
| 04/19/2007 | US20070087453 Immuno conjugate and process for preparation thereof |
| 04/19/2007 | US20070087452 Luminescent lanthanide complexes |
| 04/19/2007 | US20070087412 Metalloprotease-disintegrin ADAM23 (SVPH3-17) |
| 04/19/2007 | US20070087381 Methods for constructing scdb libraries |
| 04/19/2007 | US20070087342 Secreted proteins |
| 04/19/2007 | US20070087331 Selection of b cells with specificity if interest: method of preparation and use |
| 04/19/2007 | US20070087330 Viral deconstruction through capsid assembly in vitro |
| 04/19/2007 | US20070087019 Moraxella catarrhalis outer membrane protein-106 polypeptide, gene sequence and uses thereof |
| 04/19/2007 | US20070087018 Omp85 proteins of Neisseria gonorrhoeae and Neisseria meningitidis, compositions containing same and methods of use thereof |
| 04/19/2007 | US20070087007 Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens |
| 04/19/2007 | US20070087006 Compositions and methods for the diagnosis and treatment of tumor |
| 04/19/2007 | US20070087005 Anti-glypican-3 antibody |
| 04/19/2007 | US20070087004 Pro104 antibody compositions and methods of use |
| 04/19/2007 | US20070087003 Methods of treating a blood pathology using anti-TNF antibodies and fragments thereof |
| 04/19/2007 | US20070087000 Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8-associated disorders |
| 04/19/2007 | US20070086999 Compositions and methods including a recombinant human mab that promotes cns remyelination |
| 04/19/2007 | US20070086998 Therapeutic human anti-mhc class II antibodies and their uses |
| 04/19/2007 | US20070086997 Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes |
| 04/19/2007 | US20070086994 Anti-nik antibodies and uses thereof |
| 04/19/2007 | US20070086950 GAT2 transporters expressed in blood brain barrier cells |
| 04/19/2007 | US20070086943 antibodies that immunospecifically bind to tyrosine kinase receptors (EphA2) and competes for binding to EphA2 with the EA5 antibody, used for cancer therapy |
| 04/19/2007 | US20070086942 Methods and compositions for generating bioactive assemblies of increased complexity and uses |
| 04/19/2007 | CA2639119A1 Agent for preventing/treating cancer |
| 04/19/2007 | CA2625998A1 Optimized anti-cd30 antibodies |
| 04/19/2007 | CA2625681A1 Generation and profiling of fully human hucal gold-derived therapeutic antibodies specific for human cd38 |
| 04/19/2007 | CA2625440A1 Compositions comprising cross-species-specific antibodies and uses thereof |
| 04/19/2007 | CA2625222A1 Antibody polypeptide library screening and selected antibody polypeptides |
| 04/19/2007 | CA2624976A1 Anti-myostatin antibodies |
| 04/19/2007 | CA2624781A1 Nanobodies tm and polypeptides against egfr and igf-ir |
| 04/19/2007 | CA2623109A1 Compositions and methods for treating proliferative disorders |
| 04/19/2007 | CA2590399A1 Methods and compositions for detecting bacillus anthracis |
| 04/18/2007 | EP1775307A2 Bispecific antibody effective to treat B-cell lymphoma and cell line |
| 04/18/2007 | EP1774331A2 Cytoxan antibodies and immunoassay |
| 04/18/2007 | EP1774329A2 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 04/18/2007 | EP1774037A2 Assays and methods using biomarkers |
| 04/18/2007 | EP1774033A2 Multiplexing assays for analyte detection |
| 04/18/2007 | EP1774031A2 Cancer treatment method by inhibiting mage gene expression or function |
| 04/18/2007 | EP1774023A2 Markers for brain damage |
| 04/18/2007 | EP1774019A2 Look-through mutagenesis for developing altered polypeptides with enhanced properties |
| 04/18/2007 | EP1773886A1 Improved method of selecting a desired protein from a library |
| 04/18/2007 | EP1773885A2 Humanized anti-cmet antagonists |
| 04/18/2007 | EP1773884A2 Therapeutic and diagnostic methods and compositions targeting 4ig-b7-h3 and its counterpart nk cell receptor |
| 04/18/2007 | EP1773883A2 Antibodies against cancer produced using masked cancer cells as immunogen |
| 04/18/2007 | EP1773882A2 Diagnosis and treatment of siglec-6 associated diseases |
| 04/18/2007 | EP1773881A2 Inhibition of macrophage-stimulating protein receptor (ron) |
| 04/18/2007 | EP1773880A2 Env polypeptide complexes and methods of use |
| 04/18/2007 | EP1773867A2 Proteinaceous compounds and uses therefor |
| 04/18/2007 | EP1773393A2 Preventing autoimmune disease by using an anti-cd20 antibody |
| 04/18/2007 | EP1773392A2 Method for preventing and treating mast cell mediated diseases |
| 04/18/2007 | EP1773391A2 Increasing the production of recombinant antibodies in mammalian cells by site-directed mutagenesis |
| 04/18/2007 | EP1773390A2 Improved therapeutic agent for inos generating illness |
| 04/18/2007 | EP1773383A2 Antibodies as t cell receptor mimics, methods of production and uses thereof |
| 04/18/2007 | EP1773380A1 Hai-1 and hai-2 in cancer therapy |
| 04/18/2007 | EP1611250A4 Detection of urinary mesothelin-/megakaryocyte potentiating factor-related peptides for assessment of ovarian cancer |
| 04/18/2007 | EP1589995B1 Use of avian antibodies |
| 04/18/2007 | EP1527098A4 Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof |
| 04/18/2007 | EP1428835B1 Antibody against metastin and use of the same in the diagnosis of pregnancy |
| 04/18/2007 | EP1379266B1 Modified annexin proteins and prevention and treatment of thrombosis |
| 04/18/2007 | EP1352063B1 Receptor nucleic acids and polypeptides |
| 04/18/2007 | EP1335976B1 Modifier of organelle metalbolism |
| 04/18/2007 | EP1334194B1 Imaging, diagnosis and treatment of disease |
| 04/18/2007 | EP1324652B1 Transgenic drosophila melanogaster expressing beta amyloid |
| 04/18/2007 | EP1307490B1 Fv- CONSTRUCTS WITH AN INFLUENCEABLE AFFINITY FOR A SUBSTANCE THAT IS TO BE LINKED |
| 04/18/2007 | EP1283720B1 Recombinant or purified polyclonal antibodies for treating allergy |
| 04/18/2007 | EP1206549B1 Basb119 polypeptide and polynucleotide from moraxella catarrhalis |
| 04/18/2007 | EP1192261B1 22025, a novel human cyclic nucleotide phosphodiesterase |
| 04/18/2007 | EP1135160B1 Boron neutron capture therapy using pre-targeting methods |
| 04/18/2007 | EP1079843B1 Use of alfa1beta1 integrin receptor inhibitors and tgf- beta1 inhibitors in the treatment of kidney disease |
| 04/18/2007 | EP1012282B1 Cysteine rich receptors-train |
| 04/18/2007 | EP1004669B1 Novel differentiation inhibitor |
| 04/18/2007 | EP0960117B1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE |
| 04/18/2007 | EP0765169B1 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the pedf gene |
| 04/18/2007 | CN1950518A Compositions and methods for characterizing, regulating, diagnosing, and treating cancer |
| 04/18/2007 | CN1950496A Production of galactosylated glycoproteins in lower eukaryotes |
| 04/18/2007 | CN1950399A Less immunogenic binding molecules |
| 04/18/2007 | CN1950396A 抗真菌肽 Antifungal Peptide |
| 04/18/2007 | CN1950107A Anti-IRTA-5 antibodies and use thereof |
| 04/18/2007 | CN1948492A Human hZNF shgc gene sequence, its coding protein and preparation method |
| 04/18/2007 | CN1948491A Human hZNF216-iso gene sequence, its coding protein and preparation method |
| 04/18/2007 | CN1948490A Human hRAB-14 gene sequence, its coding protein and preparation method |
| 04/18/2007 | CN1948489A Human hTCRrp gene sequence, its coding protein and preparation method |
| 04/18/2007 | CN1948488A Human hILF-1-iso gene sequence, its coding protein and preparation method |
| 04/18/2007 | CN1948487A Human ad-ZNF 127 xp gene sequence, its coding protein and preparation method |
| 04/18/2007 | CN1948486A Human hGPR-iso gene sequence, its coding protein and preparation method |
| 04/18/2007 | CN1948485A Human hp52-ap gene sequence, its coding protein and preparation method |
| 04/18/2007 | CN1948476A High-function antibody biosynthesis |
| 04/18/2007 | CN1948343A Tetravalence single chain antibody of p53 tetra polymerized structure domain |
| 04/18/2007 | CN1948335A Candida albicans mycellium regulating and controlling factor gene and its use |
| 04/18/2007 | CN1948334A Candida albicans cell wall adhesion factor gene and its use |